Access cutting-edge chronic kidney disease treatment through this clinical trial at a research site in Seattle. Study-provided care at no cost to qualified participants.
Access chronic kidney disease specialists in Seattle at no cost
This study follows strict safety protocols and ethical guidelines
All study-related chronic kidney disease treatment provided free
The overall goal of the study is to determine if treatment of a Major Depressive Disorder (MDD) improves the outcomes of patients with chronic kidney disease (CKD). We showed that MDD is present in 25% of CKD patients and independently associated with progression to End-Stage Kidney Disease, hospitalization, and death. Depression is also associated with lower quality of life (QOL), fatigue, poor sleep, and non-adherence to diet and medications. However, evidence for efficacy and tolerability of
Sponsor: Stony Brook University
Check if you qualify for this chronic kidney disease clinical trial in Seattle, WA
If you're searching for chronic kidney disease treatment options in Seattle, WA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Seattle research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chronic kidney disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.